Showing 16,041 - 16,060 results of 27,241 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (teer decrease)) ))', query time: 0.84s Refine Results
  1. 16041

    Image5_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  2. 16042

    DataSheet1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  3. 16043

    DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx by Tuo Pan (9264234)

    Published 2023
    “…Secondly, a propensity-score matched cohort (sivelestat vs control: 50 vs 50) was performed in these 665 patients. …”
  4. 16044

    Image3_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  5. 16045

    Cytoprotective gene regulation is essential to lifespan extension by diverse mechanisms. by David E. Shore (123998)

    Published 2012
    “…Lifespan was measured in three replicates comprising an average of 103 worms per condition. Data is presented as mean lifespan (columns 1–4), change mean lifespan in comparison to an empty vector RNAi control (column 5), or as the change in the extension of lifespan induced by each long-lived mutant (columns 6–8; for clarity, only decreases >15% are shown). …”
  6. 16046
  7. 16047
  8. 16048
  9. 16049
  10. 16050
  11. 16051

    DataSheet_2_IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.docx by Hortensia Álvarez (830316)

    Published 2023
    “…All of them matched their counterparts several months following ART initiation. MIG levels showed a greater decrease at day 10 in those treated with INSTI (p=0·038). …”
  12. 16052

    Metabolically healthy obesity and depressive symptoms: 16-year follow-up of the Gazel cohort study by Guy-Marino Hinnouho (3909874)

    Published 2017
    “…<div><p>Aims</p><p>The health correlates of the metabolically healthy obese (MHO) phenotype, particularly in relation to depressive symptoms remains unclear. Accordingly, we examined the risk of depressive symptoms in this phenotype using a 16-year follow-up prospective study.…”
  13. 16053

    Table_1_Implication of Non-electrostatic Contribution to Deionization in Flow-Electrode CDI: Case Study of Nitrate Removal From Contaminated Source Waters.DOCX by Jingke Song (526928)

    Published 2019
    “…Through periodic replacement of the electrolyte at a water recovery of 91.4%, we show that the FCDI system can achieve a continuous desalting performance with the effluent NO<sub>3</sub>-N concentration below 1 mg NO<sub>3</sub>-N L<sup>−1</sup> at low energy consumption (~0.5 kWh m<sup>−3</sup>) but high productivity.…”
  14. 16054

    DataSheet_1_IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.zip by Hortensia Álvarez (830316)

    Published 2023
    “…All of them matched their counterparts several months following ART initiation. MIG levels showed a greater decrease at day 10 in those treated with INSTI (p=0·038). …”
  15. 16055

    Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36 by Grace E. Cooper (3193272)

    Published 2016
    “…Concurrently, there was a significant increase in IFNβ gene expression in response to infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFNβ. …”
  16. 16056

    Hepatoprotective and antioxidant effect of ellagitannins and galloyl esters isolated from <i>Melaleuca styphelioides</i> on carbon tetrachloride-induced hepatotoxicity in HepG2 cel... by Eman Al-Sayed (2934060)

    Published 2016
    “…(Myrtaceae) showed a significant hepatoprotective effect in a CCl<sub>4</sub>-induced toxicity model in mice. …”
  17. 16057

    Effects of MBHA3 treatment on the acidic compartments of T. cruzi. by Jana M. Sandes (548760)

    Published 2014
    “…Nevertheless, in cells treated with the 4x IC<sub>50</sub> of MBHA3, a striking decrease of the fluorescent signal from red channel was observed. …”
  18. 16058
  19. 16059

    Comparison of urinary NGF/Cr and BDNF/Cr levels in clinical responders and non-responders after intravesical hyaluronic acid treatment in IC/BPS patients. by Yuan-Hong Jiang (398786)

    Published 2014
    “…</p>$<p>Responder in FBC: increase of ≥ 50% of baseline.</p><p>Data are expressed as mean ± standard deviation.…”
  20. 16060

    Factor analysis of abnormal postural change cardiovascular autonomic indices within pSS patients by Fin ZJ Cai (51289)

    Published 2011
    “…RR intervals, low frequency RR power (HRV), proportion of successive RR intervals differing by more than 50 ms (pNN50), change in systolic blood pressure on standing (ΔSBP), low frequency systolic blood pressure power (BPV) and the 30/15 ratio were all decreased in patients who have primary Sjögren's syndrome (pSS) relative to control individuals on standing. …”